COURSE 1:DSM-IV-TRCULTURAL FORMULATIONS: DIAGNOSIS AND
THERAPY
Director: Russell F. Lim, M.D. Faculty: Frank Brown, M.D.,
David C. Henderson, M.D., Roberto Lewis-Fernandez, M.D., Francis G. Lu, M.D.,
J. Charles Ndlela, M.D. Educational Objective: At the conclusion of
this course, the participant should be able to (1) understand and describe the
five parts of the DSM-IV-TR outline for cultural formulation; (2) be
able to apply it to the treatment of three of the following four groups:
African-American, Asian, Hispanic, and American-Indian patients; and (3)
understand how ethnicity affects psychopharmacology and psychotherapy.
Course Level: This is a basic course. No prior experience or knowledge
is required. This is a revision of a course given last year. Sat., May 21,
8-12; Georgia World Congress Center; fee: advance $100, on site $130; spaces
available: 30
COURSE 2: THE EVALUATION AND IDENTIFICATION OF THE MAJOR
DEMENTIAS
Director: Raymond A. Faber, M.D. Faculty: Kevin F. Gray,
M.D., Randolph B. Schiffer, M.D. Educational Objective: At the
conclusion of this course, the participant should be able to (1) evaluate all
major cognitive and higher cortical functions; (2) utilize any of several
cognitive and executive function screening batteries; (3) recognize the most
common presentations and course of Alzheimer's disease and appreciate the
behavioral disorders that most frequently complicate Alzheimer's disease; and
(4) differentiate Lewy body dementia, frontotemporal dementias, and vascular
dementias from Alzheimer's disease. Course Level: This is an
intermediate course. Participants should have experience in treating patients
with dementia. This is a repeat of a course given last year. Sat., May 21,
8-12; Georgia World Congress Center; fee: advance $100, on site $130; spaces
available: 100
COURSE 3: ADD IN CHILDREN AND ADOLESCENTS
Director: Thomas E. Brown, Ph.D. Faculty: Jefferson B.
Prince, M.D. Educational Objective: At the conclusion of this course,
the participant should be able to (1) recognize types of child and adolescent
attention-deficit disorders (ADDs); (2) assess and diagnose ADDs using updated
instruments and methods; (3) select appropriate medications for ADDs with
comorbid conditions; and (4) design multimodal treatment programs for ADD
children and adolescents. Course Level: This is a basic course. No
previous experience or knowledge is required. This is a repeat of a course
given last year. Sat., May 21, 8-12; Georgia World Congress Center; fee:
advance $100, on site $130; spaces available: 125. Similar courses on this
topic will be offered on Sun., May 22, 8-12; Tue., May 24, 1-5; and Thu., May
26, 8-12. See Courses 18, 76, and 101 for
details.FIG1
COURSE 4: ESSENTIALS OF GERIATRIC PSYCHIATRY
Director: Joel Streim, M.D. Educational Objective: At the
conclusion of this course, the participant should be able to (1) understand
the basic principles of geriatric psychopharmacology and pharmacokinetic
changes associated with aging; (2) understand the current approaches to
diagnosing and treating geriatric depression and late-life depressive-spectrum
disorders; (3) diagnose and know how to use pharmacotherapy in the treatment
of late-life bipolar disorder; (4) learn three effects or consequences of
psychosis and agitation that may warrant the use of psychotropic drugs for
geriatric patients with dementia; (5) know common neurotransmitter effects of
drugs that can complicate the clinical care of older adults with medical
comorbidity; (6) understand the need for risk assessment and monitoring in the
use of antipsychotic drugs for elderly patients with dementia; (7) know
different pharmacological agents for use in the treatment of alcohol
dependence, opioid dependence, and nicotine dependence; (8) understand the
significant cohort changes in the prevalence of addiction and the relevance of
addiction to the practice of geriatric psychiatry; (9) know the basic
mechanisms underlying the pharmacotherapy of addiction; (10) gain familiarity
with the potential clinical presentation of serious mental illness during
menopause; and (11) better understand treatment options for serious mental
illness during menopause. Course Level: This is an intermediate course.
Basic knowledge of psychopharmacology is desirable. Sat., May 21, 9-4;
Georgia World Congress Center; fee: advance $100, on site $130; spaces
available: 50. Similar courses on this topic will be offered on Wed., May 25,
9-4, and 1-5. See Courses 88 and 100 for details.
COURSE 5: TRANSPERSONAL PSYCHIATRY: CLINICAL APPLICATIONS
Co-Directors: John F. Hiatt, M.D., William W. Foote, M.D.
Educational Objective: At the conclusion of this course, the
participant should be able to (1) use techniques for inducing nonordinary
states of consciousness; (2) understand proper use of the techniques and
identify persons suitable for them; and (3) acquire initial competency in
their use to facilitate psychotherapy. Course Level: This is an
intermediate course. Participants should have experience with spiritual
practice. Sat., May 21, 9-4; Georgia World Congress Center; fee: advance
$160, on site $185; spaces available: 25
COURSE 6: THERAPEUTIC INTERVENTIONS IN EATING DISORDERS: BASIC
PRINCIPLES
Director: David C. Jimerson, M.D. Faculty: Michael J. Devlin,
M.D., Katherine A. Halmi, M.D., James E. Mitchell, M.D., Joel Yager, M.D.
Educational Objective: At the conclusion of this course, the
participant should be able to (1) perform a comprehensive clinical assessment
of patients with eating disorders and (2) plan initial treatment, considering
short-term psychotherapy and pharmacotherapy. Course Level: This is a
basic course. No previous experience or knowledge is required. This is a
repeat of a course given last year. Sat., May 21, 9-4; Georgia World Congress
Center; fee: advance $160, on site $185; spaces available: 50
COURSE 7: UPDATES IN NEUROPSYCHIATRY: DELIRIUM, TRAUMATIC BRAIN INJURY,
AND POSTSTROKE AND POST-MI DEPRESSION
Director: Jose R. Maldonado, M.D. Faculty: Marshal Folstein,
M.D. Educational Objective: At the conclusion of this course, the
participant should be able to (1) assess the presence of delirium, poststroke
depression, and traumatic brain injury (TBI) in the clinical setting; (2)
understand the incidence, epidemiology, and clinical features of these three
neuropsychiatric disorders; and (3) review the latest data regarding treatment
and outcomes. Course Level: This is a basic course. No prior experience
or knowledge is required. This is a repeat of a course given last year.
Sat., May 21, 9-4; Georgia World Congress Center; fee: advance $160, on site
$185; spaces available: 50. A similar course on this topic will be offered on
Mon., May 23, 9-4. See Course 47 for
details.FIG2
COURSE 8: INFANTICIDE: A DIALOGUE BETWEEN THE ATTORNEY AND THE
PSYCHIATRIST
Director: Margaret G. Spinelli, M.D. Faculty: Katherine L.
Wisner, M.D., Deborah Denno, J.D. Educational Objective: At the
conclusion of this course, the participant should be able to (1) provide a
framework for early identification and treatment of women at risk; (2) assist
psychiatrists who face the challenges of the criminal court system; (3)
provide a basis for liaison between the legal system and mental health; (4)
know what to learn from the attorney about the court; (5) know what to teach
the attorney about psychiatric diagnosis; and (6) emphasize the need for
formal diagnostic guidelines in DSM for postpartum disorders.
Course Level: This is a basic course. No prior experience or knowledge
is required. Sat., May 21, 1-5; Georgia World Congress Center; fee: advance
$100, on site $130; spaces available: 25. A similar course on this topic will
be offered on Mon., May 23, 1-5. See Course 56 for details.
COURSE 9: PSYCHIATRIC INTERVENTIONS IN DISASTERS AND PUBLIC HEALTH
EMERGENCIES: THEORY TO PRACTICE
APA Committee on Psychiatric Dimensions of Disaster.Director: Anthony T. Ng, M.D. Faculty: Molly J. Hall, M.D.,
Judith A. Cohen, M.D., Phebe M. Tucker, M.D. Educational Objective: At
the conclusion of this course, the participant should be able to (1) define
disaster as a mental health issue; (2) identify relationship and need for
integration between mental health and public health in overall disaster
responses; (3) identify organizational elements of community response to
disasters; (4) assess individuals exposed to disasters and other major
traumas; (5) differentiate normal from pathologic responses, directing
individuals to appropriate interventions; (6) describe posttraumatic mental
health effects on children and adults; (7) discuss appropriate management
strategies for postdisaster PTSD in children and adults; (8) identify and
discuss special challenges and issues encountered by psychiatrists in disaster
mental health, as well as strategies to deal with those issues and challenges;
and (9) describe the roles of the APA Committee on Psychiatric Dimensions of
Disaster and APA district branches in disaster mental health. Course
Level: This is a basic course. No experience or knowledge is required.
This is a revision of a course given last year. Sat., May 21, 1-5; Georgia
World Congress Center; fee: advance $100, on site $130; spaces available: 75.
A similar course on this topic will be offered on Mon., May 23, 8-12. See
Course 37 for details.
COURSE 10: STREET DRUGS AND MENTAL DISORDERS: OVERVIEW AND
TREATMENT
Director: John W. Tsuang, M.D. Faculty: Tim Fong, M.D., Karen
A. Miotto, M.D. Educational Objective: At the conclusion of this
course, the participant should be able to understand the issues and
difficulties relating to the treatment of dual-diagnosis patients. The
available pharmacological agents for treatment of dual-diagnosis patients and
medication treatment for substance-dependence disorders will be covered.
Additionally, participants will learn the harm-reduction versus the abstinence
model for dual-diagnosis patients. Course Level: This is a basic
course. No previous experience or knowledge is required. This is a repeat
of a course given last year. Sat., May 21, 1-5; Georgia World Congress Center;
fee: advance $100, on site $130; spaces available: 50
COURSE 11: MELATONIN AND LIGHT TREATMENT OF SAD, SLEEP, AND OTHER
BODY-CLOCK DISORDERS
Director: Alfred J. Lewy, M.D. Educational Objective: At the
conclusion of this course, the participant should be able to add melatonin and
bright light to treatment regimens of winter depression, shift work
maladaptation, jet lag, and certain types of sleep disorders, including those
of totally blind people. Course Level: This is a basic course. No
experience or knowledge is required. This is a revision of a course given
last year. Sat., May 21, 1-5; Georgia World Congress Center; fee: advance
$100, on site $130; spaces available: 100
COURSE 12: DOING RESEARCH ON A SHOESTRING BUDGET
Director: Mantosh J. Dewan, M.D. Faculty: Michele T. Pato,
M.D., Edward K. Silberman, M.D. Educational Objective: At the
conclusion of this course, the participant should be able to (1) develop ideas
into research projects; (2) develop strategies for supporting projects without
grant funding; and (3) get results published. Course Level: This is a
basic course. No experience or knowledge is required. This is a revision of
a course given last year. Sat., May 21, 1-5; Georgia World Congress Center;
fee: advance $100, on site $130; spaces available: 25